Neurology Department (ICU)

The Department of Neurology was the earliest authorized site in western China to confer doctoral degrees in a first-level discipline, and established a postdoctoral research station in 1995. In November 1990, the Institute of Neurology was established with approval from the Sichuan Provincial Education Commission; Professor Fu Yage served as its director in 1991, followed by Professor Dong Weiwei in 1996. In 1996, it was approved as a key discipline by the Sichuan Education Commission; in 1997, the National Drug Clinical Research Base for Neurology was established with approval from the State Food and Drug Administration. In 1999, it became one of the first Chongqing municipal key medical disciplines, and subsequently established the Chongqing Key Laboratory of Medical Sciences, the Chongqing Key Laboratory for Institutions of Higher Education, and the Chongqing Provincial-Ministerial Key Laboratory of Neurobiology; in 2007, it became the only National Key Discipline of Neurology under the Ministry of Education in western China (only 6 nationwide); in 2009, the Chongqing Medical Quality Control Center for Neurology was approved; at the end of 2010, it was approved as the Ministry of Health’s “Stroke Screening, Prevention and Treatment Base.” In 2012, it was approved for the National Clinical Key Specialty Construction Project of the National Health Commission; in 2014, it passed the acceptance inspection of the National Health Commission Brain Injury Quality Control Evaluation Center, becoming one of the first units in Chongqing to qualify for national quality control of brain-death determination. In 2018, the Chongqing Brain Injury Assessment Quality Control Center was approved. In 2019, the National Health Commission Key Laboratory for the Diagnosis and Treatment of Functional Brain Diseases was approved. In 2021, the Chongqing Key Laboratory of Major Neuropsychiatric Diseases was approved. In recent years, the discipline’s scientific and technological value metric has consistently ranked among the top 10 in the China Hospital Science and Technology Influence Ranking, and it has consistently received a national nomination in the Fudan Specialty Reputation Ranking. The Department of Neurology of the First Affiliated Hospital of Chongqing Medical University has established a new coordinated development pattern of “one hospital, three campuses,” and currently has 248 open beds, including 21 intensive care unit beds. Patients from outside the city come from more than 20 provinces, municipalities, and autonomous regions across China. The discipline has a comprehensive range of clinical subspecialties, with its subspecialties in cerebrovascular disease, epilepsy, infection and neuroimmunology, neuromuscular diseases, and neuropsychology at the forefront in China. The Department of Neurology has produced and trained a large number of high-level medical, teaching, and research professionals in neurology, forming a strong academic team. Department leaders and young and mid-career academic leaders hold important positions in national academic organizations, including member of the Ministry of Education Degree Evaluation Committee, chair of the Neurology Specialty Editorial Committee for the National Periodic Physician Assessment, former vice chair of the Neurology Branch of the Chinese Medical Association, president of the Neurologists Branch of the Chinese Medical Doctor Association, deputy leader of the Epilepsy and Electroencephalography Group of the Neurology Branch of the Chinese Medical Association, members of the Neuroimmunology Group, Movement Disorders Group, and Dementia Group of the Neurology Branch of the Chinese Medical Association, and deputy chairs of the Specialist Committees on Cerebrovascular Disease, Epilepsy, Pain and Sensation of the Neurologists Branch of the Chinese Medical Doctor Association, among other important academic appointments. It currently has 19 professors, 20 associate professors, and 8 lecturers; 11 doctoral supervisors and 30 master’s supervisors. It has 1 chief scientist of the “973” Program, 1 recipient of the National Innovation and Endeavor Award, 1 member of the Hundred-Thousand-Ten Thousand Talent Project, 4 young and middle-aged experts with outstanding contributions recognized by the National Health Commission, 1 recipient of the National Science Fund for Excellent Young Scholars, and 1 expert with outstanding contributions to the National Health Commission Brain Prevention Committee; 8 recipients of the State Council Government Special Allowance and 3 participants in the China Association for Science and Technology Youth Talent Support Project. It has led 7 national major (key) projects; its results have been published in top medical journals including The New England Journal of Medicine and The Lancet, and have reshaped relevant international and domestic diagnostic and treatment guidelines. It has received 2 second prizes and 2 third prizes of the National Science and Technology Progress Award.